Experiences of Response Measures against the 4 Suspected Cases of Ebola Virus Disease from West Africa in the National Center for Global Health and Medicine, Tokyo, Japan

Satoshi Kutsuna; Kei Yamamoto; Nozomi Takeshita; Kayoko Hayakawa; Yasuyuki Kato; Shuzo Kanagawa; Yuko Sugiki; Norio Ohmagari

doi:10.7883/yoken.JJID.2016.508

Short Communication

Experiences of Response Measures against the 4 Suspected Cases of Ebola Virus Disease from West Africa in the National Center for Global Health and Medicine, Tokyo, Japan

Satoshi Kutsuna, Kei Yamamoto, Nozomi Takeshita, Kayoko Hayakawa, Yasuyuki Kato, Shuzo Kanagawa, Yuko Sugiki, Norio Ohmagari

Author information

Satoshi Kutsuna
Disease Control and Prevention Center, National Center for Global Health and Medicine
Kei Yamamoto
Disease Control and Prevention Center, National Center for Global Health and Medicine
Nozomi Takeshita
Disease Control and Prevention Center, National Center for Global Health and Medicine
Kayoko Hayakawa
Disease Control and Prevention Center, National Center for Global Health and Medicine
Yasuyuki Kato
Disease Control and Prevention Center, National Center for Global Health and Medicine
Shuzo Kanagawa
Disease Control and Prevention Center, National Center for Global Health and Medicine
Yuko Sugiki
Infection Control Team, National Center for Global Health and Medicine
Norio Ohmagari
Disease Control and Prevention Center, National Center for Global Health and Medicine

Keywords: Ebola virus disease, infectious diseases, Ebola virus, category 1 infectious diseases

JOURNAL FREE ACCESS

2018 Volume 71 Issue 1 Pages 62-64

DOI https://doi.org/10.7883/yoken.JJID.2016.508

Browse “Advance online publication” version

Details

Abstract

In Japan, infectious diseases are classified into 4 types based on how contagious and severe the pathogens are, and Ebola virus disease (EVD) is categorized as a category 1 infectious disease. The National Center for Global Health and Medicine in Tokyo, Japan, is designated as a specified hospital for category 1 infectious disease patients and has experienced 4 probable cases of EVD from West Africa. Even after the outbreak in West Africa is ended, we should continue to pay attention for new EVD outbreaks. Increasing the number of infectious disease specialists with the proper knowledge of viral hemorrhagic fever, including EVD, is a common problem for infectious disease physicians working in Japan, the academic society, and the government.

Corresponding author

Register with J-STAGE for free!